YX-2-107

CAS No. 2417408-46-7

YX-2-107( —— )

Catalog No. M36609 CAS No. 2417408-46-7

YX-2-107 is a selective and potent CDK6-degrading PROTAC with an IC50 value of 4.4 nM.YX-2-107 inhibits RB phosphorylation and FOXM1 expression in vitro, and inhibits the development of Ph+ ALL in rats.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 344 Get Quote
5MG 535 Get Quote
10MG 852 Get Quote
25MG 1527 Get Quote
50MG 2291 Get Quote
100MG 3024 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    YX-2-107
  • Note
    Research use only, not for human use.
  • Brief Description
    YX-2-107 is a selective and potent CDK6-degrading PROTAC with an IC50 value of 4.4 nM.YX-2-107 inhibits RB phosphorylation and FOXM1 expression in vitro, and inhibits the development of Ph+ ALL in rats.
  • Description
    YX-2-107 is a PROTAC (IC50= 4.4 nM) that selectively degrades CDK6. YX-2-107 effectively inhibits RB phosphorylation and FOXM1 expression in vitro and inhibits the development of Ph+ ALL in rats. YX-2-107 can be used in the study of Ph chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL).
  • In Vitro
    YX-2-107 (2000 nM; 48 h) shows inhibition of S phase in Ph+ BV173 and SUP-B15 cells.YX-2-107 (0, 1.6, 8, 40, 200, 1000 nM;4 h) selectively degrades CDK6 in BV173 cells.YX-2-107 (2000 nM; 72 h) inhibits RB phosphorylation and FOXM1 expression in Ph+ BV173 and SUP-B15 cells.Cell Cycle Analysis Cell Line:Ph+ BV173 and SUP-B15 cells Concentration:2000 nM Incubation Time:48 h Result:Inhibited S-phase entry.Western Blot Analysis Cell Line:Ph+ BV173 and SUP-B15 cells Concentration:2000 nM Incubation Time:72 h Result:Inhibited the phosphorylation of RB and the expression of FOXM1.
  • In Vivo
    YX-2-107 (10 mg/kg; i.p.; single) shows a maximum concentration of 741 nM (150-fold greater than CDK6 degradation IC50), with clearance from the plasma after 4 hours.YX-2-107 (150 mg/kg; i.p.; single daily for 3 days) is pharmacologically active in suppressing Ph+ ALL proliferation in mice.Animal Model:NRG-SGM3 mice (Ph+ ALL xenografts model).Dosage:150 mg/kg Administration:Intraperitoneal injection; single daily for 3 days Result:Suppressed the percentage of primary Ph+ ALL S-phase cells, the expression of CDK4/6-regulated phospho-RB and, to a lesser degree, FOXM1, and induced the selective CDK6 degradation.Animal Model:C57BL/6j mice.Dosage:10 mg/kg Administration:Intraperitoneal injection.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    PROTACs | CDK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2417408-46-7
  • Formula Weight
    889.95
  • Molecular Formula
    C45H51N11O9
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (112.37 mM; Ultrasonic )
  • SMILES
    O=C1NC(=O)C(N2C(=O)C=3C=CC=C(OCC(=O)NCCCCNCC(=O)N4CCN(C5=CN=C(C=C5)NC=6N=CC7=C(N6)N(C(=O)C(C(=O)C)=C7C)C8CCCC8)CC4)C3C2=O)CC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. De Dominici M, et al. Selective inhibition of Ph-positive ALL cell growth through kinase-dependent and -independent effects by CDK6-specific PROTACs. Blood. 2020 Apr 30;135(18):1560-1573.?
molnova catalog
related products
  • Levomenol

    Levomenol is a sesquiterpene alcohol that has been found in the essential oils of several aromatic plants with exerts antioxidant anti-inflammatory and anti-apoptotic activities.?

  • Galanin Receptor Lig...

    Galanin Receptor Ligand M35 TFA is a high-affinity ligand and antagonist of galanin receptor (Kd=0.1 nM).

  • 2-(4-Methoxyphenyl)a...

    2-(4-Methoxyphenyl)acetic acid is a plasma metabolite found in normal human urine cerebrospinal fluid and brain tissue.